CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
An exciting enhancement is implementing January 20, 2020 in our Special Testing laboratory as we mov...
This is the first update to the original CTS communication distributed on July 6th. As previously co...
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...